SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Increase (Decrease) in Accounts Payable, Trade
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Increase (Decrease) in Accounts Payable, Trade of -$382.88 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2023-03-15
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in accounts payable, trade for the quarter ending 2022-12-31 was $9.59K, a 96.88% decline year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in accounts payable, trade for the quarter ending 2021-12-31 was $307.70K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in accounts payable, trade for fiscal 2022 was -$382.88K, a 222.98% decline from fiscal 2021.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in accounts payable, trade for fiscal 2021 was $311.35K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|
| 2022-12-31 | $9.59K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$382.88K 10-K · filed 2023-03-15 | |
| 2022-09-30 | -$392.47K 10-Q · filed 2022-11-14 | ||
| 2021-12-31 | $307.70K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $311.35K 10-K · filed 2023-03-15 | |
| 2021-09-30 | $3.65K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |